Xiangyu Che

1.2k total citations
46 papers, 905 citations indexed

About

Xiangyu Che is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Xiangyu Che has authored 46 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Xiangyu Che's work include Ferroptosis and cancer prognosis (13 papers), Renal cell carcinoma treatment (12 papers) and Cell death mechanisms and regulation (7 papers). Xiangyu Che is often cited by papers focused on Ferroptosis and cancer prognosis (13 papers), Renal cell carcinoma treatment (12 papers) and Cell death mechanisms and regulation (7 papers). Xiangyu Che collaborates with scholars based in China and South Korea. Xiangyu Che's co-authors include Guangzhen Wu, Xishuang Song, Qifei Wang, Dequan Liu, Deyong Yang, Quanlin Li, Jianbo Wang, Xiaochi Chen, Feng Chen and Xiancheng Li and has published in prestigious journals such as Frontiers in Immunology, Cytokine & Growth Factor Reviews and Experimental Biology and Medicine.

In The Last Decade

Xiangyu Che

46 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyu Che China 18 489 256 211 183 155 46 905
Xishuang Song China 18 517 1.1× 260 1.0× 180 0.9× 240 1.3× 122 0.8× 54 905
Jun Xiao China 20 646 1.3× 477 1.9× 178 0.8× 178 1.0× 188 1.2× 78 1.1k
Hayahito Nomi Japan 14 246 0.5× 182 0.7× 172 0.8× 147 0.8× 126 0.8× 52 627
Zhenghui Guo China 13 359 0.7× 239 0.9× 128 0.6× 165 0.9× 101 0.7× 34 661
Qi-Shan Dai China 21 770 1.6× 426 1.7× 291 1.4× 121 0.7× 289 1.9× 39 1.2k
Jianguang Qiu China 16 246 0.5× 116 0.5× 228 1.1× 111 0.6× 85 0.5× 52 672
Juanjie Bo China 14 375 0.8× 200 0.8× 120 0.6× 162 0.9× 176 1.1× 24 679
Wenbin Huang China 16 345 0.7× 155 0.6× 246 1.2× 142 0.8× 264 1.7× 40 728
Nayara Izabel Viana Brazil 16 420 0.9× 394 1.5× 175 0.8× 110 0.6× 142 0.9× 64 752

Countries citing papers authored by Xiangyu Che

Since Specialization
Citations

This map shows the geographic impact of Xiangyu Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyu Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyu Che more than expected).

Fields of papers citing papers by Xiangyu Che

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyu Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyu Che. The network helps show where Xiangyu Che may publish in the future.

Co-authorship network of co-authors of Xiangyu Che

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyu Che. A scholar is included among the top collaborators of Xiangyu Che based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyu Che. Xiangyu Che is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Dequan, Lei Liu, Xiangyu Che, & Guangzhen Wu. (2025). Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer. Frontiers in Cell and Developmental Biology. 13. 1525345–1525345. 1 indexed citations
3.
Liu, Dequan, Shijin Wang, Shuang Liu, et al.. (2024). Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies. Molecular Aspects of Medicine. 97. 101270–101270. 41 indexed citations
4.
Liu, Dequan, Xiangyu Che, & Guangzhen Wu. (2024). Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. Biomarker Research. 12(1). 5–5. 13 indexed citations
5.
Zhao, Xinming, et al.. (2024). A Novel Approach for Bladder Cancer Treatment: Nanoparticles as a Drug Delivery System. International Journal of Nanomedicine. Volume 19. 13461–13483. 7 indexed citations
6.
Che, Xiangyu, et al.. (2022). Potential Application of Pyroptosis in Kidney Renal Clear Cell Carcinoma Immunotherapy and Targeted Therapy. Frontiers in Pharmacology. 13. 918647–918647. 7 indexed citations
7.
Xu, Yingkun, et al.. (2022). Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma. Frontiers in Cell and Developmental Biology. 10. 881490–881490. 8 indexed citations
8.
Li, Quanlin, et al.. (2021). The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC. Frontiers in Oncology. 11. 727778–727778. 55 indexed citations
9.
Che, Xiangyu, et al.. (2021). Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction. Frontiers in Medicine. 8. 731214–731214. 8 indexed citations
10.
Che, Xiangyu, et al.. (2021). Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance. Oxidative Medicine and Cellular Longevity. 2021(1). 5561124–5561124. 9 indexed citations
11.
12.
Wu, Pingan, Xiaoxia Shi, Inamullah, et al.. (2019). Taurine inhibits neuron apoptosis in hippocampus of diabetic rats and high glucose exposed HT-22 cells via the NGF-Akt/Bad pathway. Amino Acids. 52(1). 87–102. 23 indexed citations
13.
Zheng, Wei, Chunyan Zhou, Xuejian Wang, et al.. (2018). Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic death. Biomedicine & Pharmacotherapy. 106. 175–182. 37 indexed citations
14.
Wang, Qifei, Guang‐Zhi Zeng, Lin Zhong, et al.. (2016). Giant hydronephrosis due to ureteropelvic junction obstruction: A rare case report, and a review of the literature. Molecular and Clinical Oncology. 5(1). 19–22. 12 indexed citations
15.
Li, Xiancheng, Shiyong Xin, Xiangyu Che, et al.. (2014). MicroRNA-21 (miR-21) Post-Transcriptionally Downregulates Tumor Suppressor PDCD4 and Promotes Cell Transformation, Proliferation, and Metastasis in Renal Cell Carcinoma. Cellular Physiology and Biochemistry. 33(6). 1631–1642. 79 indexed citations
16.
Che, Xiangyu, et al.. (2014). Clinical research of holmium laser therapy in extramammary Paget’s disease. Lasers in Medical Science. 29(6). 1907–1912. 10 indexed citations
17.
Yang, Deyong, Qiwei Chen, Xishuang Song, et al.. (2014). Effect of lymph node dissection on the outcomes of upper tract urothelial carcinomas: a meta-analysis. Expert Review of Anticancer Therapy. 14(6). 667–675. 18 indexed citations
18.
Chen, Xiaochi, et al.. (2013). Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients. Oncology Letters. 5(4). 1278–1284. 32 indexed citations
19.
Xin, Shiyong, Deyong Yang, Xiunan Li, et al.. (2011). Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients. Journal of Cancer Research and Clinical Oncology. 138(3). 529–535. 23 indexed citations
20.
Yang, Deyong, Xishuang Song, Jianing Zhang, et al.. (2010). Suppression of Livin Gene Expression by siRNA Leads to Growth Inhibition and Apoptosis Induction in Human Bladder Cancer T24 Cells. Bioscience Biotechnology and Biochemistry. 74(5). 1039–1044. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026